Trademark: OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Click here to search for trademarks similar to OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Proof of use for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
We do not have any records of a proof of use for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION at this moment.
Click here to add a proof of use for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Possible trademark infringements of OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Basic Information about OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
- Serial Number
- 90733729
- Filing Date
- 25 May 2021
- Mark Drawing Code
- 5
Classifications
Declare the trademark use of OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION on the blockchain with WikiTrademarks.io.
- First use of OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION?
1. Novartis AG Basel
2. Novartis AG Basel
Correspondent
- Maury M. Tepper, III
- TEPPER & EYSTER, PLLC
- 3724 BENSON DR
- RALEIGH,NC 27609
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io